Evidence of cortical inhibitory deficits in major depressive disorder
- PMID: 19922906
- DOI: 10.1016/j.biopsych.2009.09.025
Evidence of cortical inhibitory deficits in major depressive disorder
Abstract
Background: Several lines of evidence suggest that major depressive disorder is associated with deficits in gamma-aminobutyric acid (GABA) inhibitory neurotransmission. Transcranial magnetic stimulation represents a noninvasive technique to measure cortical inhibition. In this study, we endeavored to measure cortical inhibition in medicated patients with treatment resistant major depressive disorder (TRD), unmedicated patients with major depressive disorder, and medicated euthymic patients with a history of major depressive disorder and compare them with healthy subjects.
Methods: Twenty-five patients with TRD, 16 unmedicated patients with major depressive disorder, 19 medicated euthymic patients with previous major depressive disorder (i.e., 17-item Hamilton Rating Scale for Depression < 8), and 25 healthy subjects were enrolled. Cortical inhibition was measured with transcranial magnetic stimulation paradigms known as short-interval cortical inhibition and the cortical silent period, which index GABA(A) and GABA(B) receptor-mediated inhibitory neurotransmission, respectively.
Results: All major depressive disorder patient groups demonstrated significant cortical silent period deficits compared with healthy subjects. By contrast, only TRD patients demonstrated significant deficits in short-interval cortical inhibition compared with healthy subjects, medicated euthymic major depressive disorder patients, and unmedicated major depressive disorder patients. The TRD patients also demonstrated a significantly greater resting motor threshold compared with all other clinical subgroups and healthy subjects, suggesting that TRD was also associated with hypoexcitability of the frontal cortex.
Conclusions: Our findings suggest that GABA(B) neurophysiological deficits are closely related to pathophysiology of major depressive disorder. Our findings also suggest that more severe illness is selectively associated with GABA(A) receptor-mediated inhibitory deficits.
Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Comment in
-
Cortical inhibition, gamma-aminobutyric acid, and major depression: there is plenty of smoke but is there fire?Biol Psychiatry. 2010 Mar 1;67(5):397-8. doi: 10.1016/j.biopsych.2010.01.003. Biol Psychiatry. 2010. PMID: 20159143 Review. No abstract available.
Similar articles
-
Evidence for impaired cortical inhibition in patients with unipolar major depression.Biol Psychiatry. 2006 Mar 1;59(5):395-400. doi: 10.1016/j.biopsych.2005.07.036. Epub 2005 Sep 28. Biol Psychiatry. 2006. PMID: 16197927
-
Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder.JAMA Psychiatry. 2013 Mar;70(3):291-9. doi: 10.1001/2013.jamapsychiatry.24. JAMA Psychiatry. 2013. PMID: 23303429
-
Antidepressant-resistant depression is characterized by reduced short- and long-interval cortical inhibition.Psychol Med. 2020 Jun;50(8):1285-1291. doi: 10.1017/S0033291719001223. Epub 2019 Jun 3. Psychol Med. 2020. PMID: 31155020
-
Evidence for GABAergic inhibitory deficits in major depressive disorder.Neurosci Biobehav Rev. 2011 Jan;35(3):818-25. doi: 10.1016/j.neubiorev.2010.10.002. Epub 2010 Oct 12. Neurosci Biobehav Rev. 2011. PMID: 20946914 Review.
-
Inhibition of the cortex using transcranial magnetic stimulation in psychiatric populations: current and future directions.J Psychiatry Neurosci. 2012 Nov;37(6):369-78. doi: 10.1503/jpn.120003. J Psychiatry Neurosci. 2012. PMID: 22663947 Free PMC article. Review.
Cited by
-
Sex-specific GABAergic microcircuits that switch vulnerability into resilience to stress and reverse the effects of chronic stress exposure.Res Sq [Preprint]. 2024 Jul 11:rs.3.rs-4408723. doi: 10.21203/rs.3.rs-4408723/v1. Res Sq. 2024. PMID: 39041032 Free PMC article. Preprint.
-
[Saikosaponin a alleviates pentylenetetrazol-induced acute epileptic seizures in mouse models of depression by suppressing microglia activation-mediated inflammation].Nan Fang Yi Ke Da Xue Xue Bao. 2024 Mar 20;44(3):515-522. doi: 10.12122/j.issn.1673-4254.2024.03.13. Nan Fang Yi Ke Da Xue Xue Bao. 2024. PMID: 38597443 Free PMC article. Chinese.
-
In-silico testing of new pharmacology for restoring inhibition and human cortical function in depression.Commun Biol. 2024 Feb 23;7(1):225. doi: 10.1038/s42003-024-05907-1. Commun Biol. 2024. PMID: 38396202 Free PMC article.
-
GABAA Receptor Availability in Relation to Cortical Excitability in Depressed and Healthy: A Positron Emission Tomography and Transcranial Magnetic Stimulation Study.Neuropsychobiology. 2024;83(1):17-27. doi: 10.1159/000535512. Epub 2023 Dec 27. Neuropsychobiology. 2024. PMID: 38151012 Free PMC article.
-
Menin Reduces Parvalbumin Expression and is Required for the Anti-Depressant Function of Ketamine.Adv Sci (Weinh). 2024 Feb;11(5):e2305659. doi: 10.1002/advs.202305659. Epub 2023 Dec 3. Adv Sci (Weinh). 2024. PMID: 38044302 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical